世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033147

新興国上位5カ国におけるジェネリック医薬品市場の概要、競合分析、および予測(2017‐2026年)

MarketLine

Top 5 Emerging Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

発刊日 2022/08/20

言語英語

体裁PDF/144ページ

ライセンス/価格144ページ

0000033147

Single
Site
Enterprisewide (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

新興国上位5カ国(ブラジル、中国、インド、メキシコ、南アフリカ)のジェネリック医薬品業界プロファイルは、市場シェア、市場規模(2017年から2021年の価値および2026年までの予測)を含むトップラインの定性的および定量的な概要情報を提供します。また、主要な財務指標や市場内の競争圧力の分析など、主要企業に関する情報も含まれています。

主要なハイライト

  • これらの国々は2021年に世界のジェネリック医薬品産業に1,129億9610万ドル貢献しており、2007年から2011年の複合年間成長率(CAGR)は7.3%でした。新興国上位5カ国は2026年には1,421億7,240百万ドルに達し、2021年から26年までのCAGRは4.7%と予測されます。
  • ジェネリック医薬品業界の中で、新興国上位5カ国の中では中国がトップで、2021年の市場売上高は853億2,700万ドルです。次いで、インドが172億8,350万ドル、メキシコが68億4,990万ドルとなっています。
  • 新興国上位5カ国では、2026年に中国が1,022億6,380万ドルでジェネリック医薬品産業をリードし、インドとメキシコがそれぞれ266億9,220万ドルと85億470万ドルで続くと予測されています。

調査範囲

  • 新興国上位5カ国のジェネリック医薬品市場の規模、成長、主要セグメント、主要プレーヤーを特定することで、初歩的な調査にかかる時間を短縮できます。
  • ファイブフォース分析により、新興国上位5カ国のジェネリック医薬品市場の競争力、魅力度を判断できます。
  • 大手企業のプロファイルは、主要なジェネリック医薬品市場における新興国上位5カ国のプレーヤーのグローバルな事業と財務実績の詳細を明らかにします。
  • 5年間の予測で新興国上位5カ国のジェネリック医薬品市場の将来の成長見通しを理解することにより、プレゼンテーションと売り込みに重みを加えることができます。
  • ブラジル、中国、インド、メキシコ、南アフリカのデータを比較し、それぞれの国について個別の章を設けています。

レポート詳細

目次

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 Top 5 Emerging Countries Generics
2.1. Industry Outlook

3 Generics in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Macroeconomic Indicators
6.1. Country data

7 Generics in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis

8 Macroeconomic Indicators
8.1. Country data

9 Generics in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis

10 Macroeconomic Indicators
10.1. Country data

11 Generics in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis

12 Macroeconomic Indicators
12.1. Country data

13 Company Profiles

14 Appendix
14.1. Methodology
14.2. About MarketLine

List of Tables
Table 1: Top 5 emerging countries generics industry, revenue ($m), 2017-26
Table 2: Top 5 emerging countries generics industry, revenue ($m), 2017-21
Table 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2021-26
Table 4: South Africa generics market value: $ million, 2016-21
Table 5: South Africa generics market volume: %, 2016-21
Table 6: South Africa generics market geography segmentation: $ million, 2021
Table 7: South Africa generics market value forecast: $ million, 2021-26
Table 8: South Africa generics market volume forecast: %, 2021-26
Table 9: South Africa size of population (million), 2017-21
Table 10: South Africa gdp (constant 2005 prices, $ billion), 2017-21
Table 11: South Africa gdp (current prices, $ billion), 2017-21
Table 12: South Africa inflation, 2017-21
Table 13: South Africa consumer price index (absolute), 2017-21
Table 14: South Africa exchange rate, 2017-21
Table 15: Brazil generics market value: $ million, 2016-21
Table 16: Brazil generics market volume: %, 2016-21
Table 17: Brazil generics market geography segmentation: $ million, 2021
Table 18: Brazil generics market value forecast: $ million, 2021-26
Table 19: Brazil generics market volume forecast: %, 2021-26
Table 20: Brazil size of population (million), 2017-21
Table 21: Brazil gdp (constant 2005 prices, $ billion), 2017-21
Table 22: Brazil gdp (current prices, $ billion), 2017-21
Table 23: Brazil inflation, 2017-21
Table 24: Brazil consumer price index (absolute), 2017-21
Table 25: Brazil exchange rate, 2017-21
Table 26: China generics market value: $ billion, 2016-21
Table 27: China generics market volume: %, 2016-21
Table 28: China generics market geography segmentation: $ billion, 2021
Table 29: China generics market value forecast: $ billion, 2021-26
Table 30: China generics market volume forecast: %, 2021-26
Table 31: China size of population (million), 2017-21
Table 32: China gdp (constant 2005 prices, $ billion), 2017-21
Table 33: China gdp (current prices, $ billion), 2017-21
Table 34: China inflation, 2017-21
Table 35: China consumer price index (absolute), 2017-21
Table 36: China exchange rate, 2017-21
Table 37: India generics market value: $ billion, 2016-21
Table 38: India generics market volume: %, 2016-21
Table 39: India generics market geography segmentation: $ billion, 2021
Table 40: India generics market value forecast: $ billion, 2021-26
Table 41: India generics market volume forecast: %, 2021-26
Table 42: India size of population (million), 2017-21
Table 43: India gdp (constant 2005 prices, $ billion), 2017-21
Table 44: India gdp (current prices, $ billion), 2017-21
Table 45: India inflation, 2017-21
Table 46: India consumer price index (absolute), 2017-21
Table 47: India exchange rate, 2017-21
Table 48: Mexico generics market value: $ million, 2016-21
Table 49: Mexico generics market volume: %, 2016-21
Table 50: Mexico generics market geography segmentation: $ million, 2021
Table 51: Mexico generics market value forecast: $ million, 2021-26
Table 52: Mexico generics market volume forecast: %, 2021-26
Table 53: Mexico size of population (million), 2017-21
Table 54: Mexico gdp (constant 2005 prices, $ billion), 2017-21
Table 55: Mexico gdp (current prices, $ billion), 2017-21
Table 56: Mexico inflation, 2017-21
Table 57: Mexico consumer price index (absolute), 2017-21
Table 58: Mexico exchange rate, 2017-21
Table 59: Aspen Pharmacare Holdings Ltd: key facts
Table 60: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 61: Aspen Pharmacare Holdings Ltd: Key Employees
Table 62: Adcock Ingram Holdings Ltd: key facts
Table 63: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 64: Adcock Ingram Holdings Ltd: Key Employees
Table 65: Sanofi SA: key facts
Table 66: Sanofi SA: Annual Financial Ratios
Table 67: Sanofi SA: Key Employees
Table 68: Sanofi SA: Key Employees Continued
Table 69: EMS SA: key facts
Table 70: EMS SA: Key Employees
Table 71: Eurofarma Laboratorios SA: key facts
Table 72: Eurofarma Laboratorios SA: Key Employees
Table 73: Ache Laboratorios Farmaceuticos SA: key facts
Table 74: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 75: Teva Pharmaceutical Industries Limited: key facts
Table 76: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 77: Teva Pharmaceutical Industries Limited: Key Employees
Table 78: Viatris Inc.: key facts
Table 79: Viatris Inc.: Annual Financial Ratios
Table 80: Viatris Inc.: Key Employees

List of Figures
Figure 1: Top 5 emerging countries generics industry, revenue ($m), 2017-26
Figure 2: Top 5 emerging countries generics industry, revenue ($m), 2017-21
Figure 3: Top 5 emerging countries generics industry forecast, revenue ($m), 2021-26
Figure 4: South Africa generics market value: $ million, 2016-21
Figure 5: South Africa generics market volume: %, 2016-21
Figure 6: South Africa generics market geography segmentation: % share, by value, 2021
Figure 7: South Africa generics market value forecast: $ million, 2021-26
Figure 8: South Africa generics market volume forecast: %, 2021-26
Figure 9: Forces driving competition in the generics market in South Africa, 2021
Figure 10: Drivers of buyer power in the generics market in South Africa, 2021
Figure 11: Drivers of supplier power in the generics market in South Africa, 2021
Figure 12: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2021
Figure 13: Factors influencing the threat of substitutes in the generics market in South Africa, 2021
Figure 14: Drivers of degree of rivalry in the generics market in South Africa, 2021
Figure 15: Brazil generics market value: $ million, 2016-21
Figure 16: Brazil generics market volume: %, 2016-21
Figure 17: Brazil generics market geography segmentation: % share, by value, 2021
Figure 18: Brazil generics market value forecast: $ million, 2021-26
Figure 19: Brazil generics market volume forecast: %, 2021-26
Figure 20: Forces driving competition in the generics market in Brazil, 2021
Figure 21: Drivers of buyer power in the generics market in Brazil, 2021
Figure 22: Drivers of supplier power in the generics market in Brazil, 2021
Figure 23: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2021
Figure 24: Factors influencing the threat of substitutes in the generics market in Brazil, 2021
Figure 25: Drivers of degree of rivalry in the generics market in Brazil, 2021
Figure 26: China generics market value: $ billion, 2016-21
Figure 27: China generics market volume: %, 2016-21
Figure 28: China generics market geography segmentation: % share, by value, 2021
Figure 29: China generics market value forecast: $ billion, 2021-26
Figure 30: China generics market volume forecast: %, 2021-26
Figure 31: Forces driving competition in the generics market in China, 2021
Figure 32: Drivers of buyer power in the generics market in China, 2021
Figure 33: Drivers of supplier power in the generics market in China, 2021
Figure 34: Factors influencing the likelihood of new entrants in the generics market in China, 2021
Figure 35: Factors influencing the threat of substitutes in the generics market in China, 2021
Figure 36: Drivers of degree of rivalry in the generics market in China, 2021
Figure 37: India generics market value: $ billion, 2016-21
Figure 38: India generics market volume: %, 2016-21
Figure 39: India generics market geography segmentation: % share, by value, 2021
Figure 40: India generics market value forecast: $ billion, 2021-26
Figure 41: India generics market volume forecast: %, 2021-26
Figure 42: Forces driving competition in the generics market in India, 2021
Figure 43: Drivers of buyer power in the generics market in India, 2021
Figure 44: Drivers of supplier power in the generics market in India, 2021
Figure 45: Factors influencing the likelihood of new entrants in the generics market in India, 2021
Figure 46: Factors influencing the threat of substitutes in the generics market in India, 2021
Figure 47: Drivers of degree of rivalry in the generics market in India, 2021
Figure 48: Mexico generics market value: $ million, 2016-21
Figure 49: Mexico generics market volume: %, 2016-21
Figure 50: Mexico generics market geography segmentation: % share, by value, 2021
Figure 51: Mexico generics market value forecast: $ million, 2021-26
Figure 52: Mexico generics market volume forecast: %, 2021-26
Figure 53: Forces driving competition in the generics market in Mexico, 2021
Figure 54: Drivers of buyer power in the generics market in Mexico, 2021
Figure 55: Drivers of supplier power in the generics market in Mexico, 2021
Figure 56: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2021
Figure 57: Factors influencing the threat of substitutes in the generics market in Mexico, 2021
Figure 58: Drivers of degree of rivalry in the generics market in Mexico, 2021

この商品のレポートナンバー

0000033147

TOP